Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity.

BACKGROUND AND PURPOSE Perfusion measurement in multiple sclerosis (MS) may cast light on the disease pathogenesis and lesion development since vascular pathology is frequently demonstrated in the disease. This study was performed to investigate the perfusion characteristics in MS lesions using dynamic susceptibility contrast MR imaging (DSC-MRI) to better understand the hemodynamic changes in MS. METHODS Seventeen patients with relapsing-remitting MS were studied with DSC-MRI. Perfusion measurements included cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT), were obtained in enhancing, non-enhancing lesions covered by DSC-MRI and contralateral normal appearing white matter (NAWM) in patients as well as normal white matter in seventeen control subjects. RESULTS DSC-MRI data demonstrated reduced perfusion with significantly prolonged MTT (P < 0.001) in lesions and NAWM in patients compared with normal white matter in controls. Compared to contralateral NAWM, enhancing lesions demonstrate increased CBF (P = 0.007) and CBV (P < 0.0001), indicating inflammation-mediated vasodilatation. A K means cluster analysis was performed and identifies approximately 63.8% of non-enhancing lesions (Class 1) with significantly decreased perfusion (P < or = 0.0001) when compared with contralateral NAWM. In contrast, the remainder 36.2% non-enhancing lesions (Class 2) show increased CBV (P = 0.02) in a similar fashion to enhancing lesions and can be observed on quantitative color-coded maps even without blood-brain barrier breakdown. CONCLUSION DSC-MRI measurements demonstrate potential for investigating hemodynamic abnormalities that are associated with inflammatory activity, lesion reactivity and vascular compromise in MS lesions. Non-enhancing lesions showed both low and high perfusion suggesting microvascular abnormalities with hemodynamic impairment and inflammatory reactivity that cannot be seen on conventional MRI.

[1]  C. Pozzilli,et al.  Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis , 2002, Acta neurologica Scandinavica.

[2]  F Barkhof,et al.  MR venography of multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[3]  K. Jellinger,et al.  The significance of perivascular infiltrations in multiple sclerosis , 1975, Journal of Neurology.

[4]  A. Wakefield,et al.  Immunohistochemical study of vascular injury in acute multiple sclerosis. , 1994, Journal of clinical pathology.

[5]  K. Hirschi,et al.  Pericytes in the microvasculature. , 1996, Cardiovascular research.

[6]  J. Petrella,et al.  Perfusion MR imaging of brain neoplasms. , 2000, AJR. American journal of roentgenology.

[7]  J. Dawson,et al.  The Histology of Disseminated Sclerosis , 1916, Edinburgh Medical Journal.

[8]  C. W. Adams,et al.  PERIVENTRICULAR LESIONS IN MULTIPLE SCLEROSIS: THEIR PERIVENOUS ORIGIN AND RELATIONSHIP TO GRANULAR EPENDYMITIS , 1987, Neuropathology and applied neurobiology.

[9]  R. Latchaw.  The roles of diffusion and perfusion MR imaging in acute stroke management. , 1999, AJNR. American journal of neuroradiology.

[10]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.

[11]  G. Johnson,et al.  Microvascular Abnormality in Relapsing-remitting Multiple Sclerosis: Perfusion Mr Imaging Findings in Normal-appearing White Matter , 2003 .

[12]  F. Ståhlberg,et al.  Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques , 2000, Magnetic resonance in medicine.

[13]  R. Poston,et al.  Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis , 1989, Journal of the Neurological Sciences.

[14]  C. Duyckaerts,et al.  Tumor necrosis factor-α, microglia and astrocytes in AIDS dementia complex , 1997, Acta Neuropathologica.

[15]  C. Duyckaerts,et al.  Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. , 1997, Acta neuropathologica.

[16]  T. J. Putnam.  The Pathogenesis of Multiple Sclerosis: A Possible Vascular Factor , 1933 .

[17]  V. Haughton,et al.  Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. , 2003, Radiology.

[18]  Oliver Speck,et al.  Perfusion MRI detects rCBF abnormalities in early stages of HIV–cognitive motor complex , 2000, Neurology.

[19]  G. Semenza.  Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. , 2000, The Journal of clinical investigation.

[20]  S. Lessell.  Retinal venous sheathing in optic neuritis: Its significance for the pathogenesis of multiple sclerosis , 1988 .

[21]  M. Könönen,et al.  Perfusion-weighted MRI in human acute ischemic stroke: a comparison with the progression of the infarct on diffusion-weighted images. , 2002, Academic radiology.

[22]  L. Steinman,et al.  Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS. , 2002, Neurology.

[23]  Hans Lassmann,et al.  Hypoxia-like tissue injury as a component of multiple sclerosis lesions , 2002, Journal of the Neurological Sciences.

[24]  Frauke Zipp,et al.  Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.

[25]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[26]  K. Jellinger,et al.  A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions. , 2003, Brain : a journal of neurology.

[27]  M. Lev,et al.  Dynamic contrast-enhanced brain perfusion imaging: technique and clinical applications. , 2000, Seminars in ultrasound, CT, and MR.

[28]  J. Balfour.  Transactions of the Royal Society of Edinburgh , 1870, Nature.

[29]  Glyn Johnson,et al.  High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. , 2002, Radiology.

[30]  T. J. Putnam.  EVIDENCES OF VASCULAR OCCLUSION IN MULTIPLE SCLEROSIS AND ENCEPHALOMYELITIS , 1937 .

[31]  K. Scheffler,et al.  Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood‐brain barrier leakage correction , 2000, Journal of magnetic resonance imaging : JMRI.

[32]  David L. Thomas,et al.  Early changes in water diffusion, perfusion, T1, and T2 during focal cerebral ischemia in the rat studied at 8.5 T , 1999, Magnetic resonance in medicine.

[33]  Glyn Johnson,et al.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. , 2002, Radiology.

[34]  H. Koprowski,et al.  Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. , 1975, The American journal of pathology.

[35]  W. J. Lorenz,et al.  Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. , 1994, Radiology.

[36]  J. Provenzale,et al.  Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging. , 2001, AJNR. American journal of neuroradiology.

[37]  D. Sims.  Recent advances in pericyte biology--implications for health and disease. , 1991, The Canadian journal of cardiology.

[38]  B. Scheithauer,et al.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.

[39]  W J Powers,et al.  Hemodynamic Effects of Middle Cerebral Artery Stenosis and Occlusion , 1998, AJNR. American journal of neuroradiology.

[40]  M Cercignani,et al.  Diffusion tensor magnetic resonance imaging in multiple sclerosis , 2001, Neurology.

[41]  Alan W. Stitt,et al.  Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. , 1995, Current eye research.

[42]  B. Rosen,et al.  Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. , 1999, Journal of neurosurgery.